ZA200710564B - Thrombin inhibiting 2-oxo- 1,2,5,6-tetrahydropyridine derivatives - Google Patents
Thrombin inhibiting 2-oxo- 1,2,5,6-tetrahydropyridine derivativesInfo
- Publication number
- ZA200710564B ZA200710564B ZA200710564A ZA200710564A ZA200710564B ZA 200710564 B ZA200710564 B ZA 200710564B ZA 200710564 A ZA200710564 A ZA 200710564A ZA 200710564 A ZA200710564 A ZA 200710564A ZA 200710564 B ZA200710564 B ZA 200710564B
- Authority
- ZA
- South Africa
- Prior art keywords
- oxo
- thrombin inhibiting
- tetrahydropyridine derivatives
- tetrahydropyridine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0501413 | 2005-06-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200710564B true ZA200710564B (en) | 2008-11-26 |
Family
ID=37532584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200710564A ZA200710564B (en) | 2005-06-17 | 2007-12-04 | Thrombin inhibiting 2-oxo- 1,2,5,6-tetrahydropyridine derivatives |
Country Status (18)
Country | Link |
---|---|
US (1) | US20080207695A1 (ru) |
EP (1) | EP1893601A1 (ru) |
JP (1) | JP2008546684A (ru) |
KR (1) | KR20080021145A (ru) |
CN (1) | CN101243069A (ru) |
AR (1) | AR054512A1 (ru) |
AU (1) | AU2006258300A1 (ru) |
BR (1) | BRPI0612045A2 (ru) |
CA (1) | CA2610428A1 (ru) |
EC (1) | ECSP088111A (ru) |
IL (1) | IL187580A0 (ru) |
MX (1) | MX2007016090A (ru) |
NO (1) | NO20076071L (ru) |
RU (1) | RU2007146731A (ru) |
TW (1) | TW200738675A (ru) |
UY (1) | UY29600A1 (ru) |
WO (1) | WO2006135323A1 (ru) |
ZA (1) | ZA200710564B (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8354444B2 (en) | 2008-09-18 | 2013-01-15 | Hoffmann-La Roche Inc. | Substituted pyrrolidine-2-carboxamides |
CN113698386B (zh) * | 2020-05-22 | 2022-12-27 | 上海美悦生物科技发展有限公司 | 一种4(1h)-吡啶酮类化合物、其药物组合物和用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11503161A (ja) * | 1995-04-04 | 1999-03-23 | メルク エンド カンパニー インコーポレーテッド | トロンビン阻害剤 |
CA2224437A1 (en) * | 1995-06-27 | 1997-01-16 | Merck & Co., Inc. | Pyridinone-thrombin inhibitors |
JP3140790B2 (ja) * | 1996-04-23 | 2001-03-05 | メルク エンド カンパニー インコーポレーテッド | ピラジノン系トロンビン阻害薬 |
US5668289A (en) * | 1996-06-24 | 1997-09-16 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
US5792779A (en) * | 1997-02-19 | 1998-08-11 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
US5866573A (en) * | 1997-04-21 | 1999-02-02 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
UA75093C2 (en) * | 2000-10-06 | 2006-03-15 | Dimensional Pharm Inc | Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors |
AU2002246675A1 (en) * | 2000-12-18 | 2002-07-30 | Merck And Co., Inc. | Thrombin inhibitors |
US6946283B2 (en) * | 2001-01-05 | 2005-09-20 | William Marsh Rice University | Ginkgo biloba levopimaradiene synthase |
WO2002064140A1 (en) * | 2001-02-09 | 2002-08-22 | Merck & Co., Inc. | Thrombin inhibitors |
SI21097A (sl) * | 2001-12-04 | 2003-06-30 | Univerza V Ljubljani | Inhibitorji trombina |
AR047521A1 (es) * | 2004-02-06 | 2006-01-25 | Astrazeneca Ab | Compuestos piridin-2-ona utiles como inhibidores de trombina |
-
2006
- 2006-06-14 BR BRPI0612045A patent/BRPI0612045A2/pt not_active IP Right Cessation
- 2006-06-14 RU RU2007146731/04A patent/RU2007146731A/ru not_active Application Discontinuation
- 2006-06-14 CN CNA2006800293561A patent/CN101243069A/zh active Pending
- 2006-06-14 UY UY29600A patent/UY29600A1/es not_active Application Discontinuation
- 2006-06-14 WO PCT/SE2006/000709 patent/WO2006135323A1/en active Application Filing
- 2006-06-14 EP EP06747902A patent/EP1893601A1/en not_active Withdrawn
- 2006-06-14 US US11/917,515 patent/US20080207695A1/en not_active Abandoned
- 2006-06-14 MX MX2007016090A patent/MX2007016090A/es not_active Application Discontinuation
- 2006-06-14 KR KR1020087001291A patent/KR20080021145A/ko not_active Application Discontinuation
- 2006-06-14 JP JP2008516787A patent/JP2008546684A/ja not_active Withdrawn
- 2006-06-14 CA CA002610428A patent/CA2610428A1/en not_active Abandoned
- 2006-06-14 AU AU2006258300A patent/AU2006258300A1/en not_active Abandoned
- 2006-06-16 TW TW095121779A patent/TW200738675A/zh unknown
- 2006-06-16 AR ARP060102570A patent/AR054512A1/es not_active Application Discontinuation
-
2007
- 2007-11-22 IL IL187580A patent/IL187580A0/en unknown
- 2007-11-27 NO NO20076071A patent/NO20076071L/no not_active Application Discontinuation
- 2007-12-04 ZA ZA200710564A patent/ZA200710564B/xx unknown
-
2008
- 2008-01-17 EC EC2008008111A patent/ECSP088111A/es unknown
Also Published As
Publication number | Publication date |
---|---|
UY29600A1 (es) | 2007-01-31 |
TW200738675A (en) | 2007-10-16 |
MX2007016090A (es) | 2008-03-10 |
JP2008546684A (ja) | 2008-12-25 |
WO2006135323A1 (en) | 2006-12-21 |
IL187580A0 (en) | 2008-03-20 |
EP1893601A1 (en) | 2008-03-05 |
ECSP088111A (es) | 2008-02-20 |
AR054512A1 (es) | 2007-06-27 |
NO20076071L (no) | 2008-01-08 |
RU2007146731A (ru) | 2009-07-27 |
US20080207695A1 (en) | 2008-08-28 |
CA2610428A1 (en) | 2006-12-21 |
BRPI0612045A2 (pt) | 2018-07-24 |
KR20080021145A (ko) | 2008-03-06 |
CN101243069A (zh) | 2008-08-13 |
AU2006258300A1 (en) | 2006-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1900034I1 (hu) | 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok | |
TWI369351B (en) | 2,4-diamino-pyrimidines as aurora inhibitors | |
IL177798A0 (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives | |
ZA200706920B (en) | Antibacterial piperidine derivatives | |
PL2420491T3 (pl) | 3,5-Podstawione piperydyny jako inhibitory reniny | |
IL192053A0 (en) | 2-adamantylurea derivatives as selective 11??-hsd1 inhibitors | |
PL1863803T3 (pl) | Podstawione piperydyny | |
IL186124A0 (en) | 3,4,5-substituted piperidines as renin inhibitors | |
EP1830858A4 (en) | 3,6-BICYCLOLIDE | |
IL195631A0 (en) | 2,5-disubstituted piperidines | |
EP1888302A4 (en) | IMPROVED BREAKING MACHINE | |
IL182538A0 (en) | 1,5-diheterocycle-1h-triazole derivative | |
ZA200705852B (en) | 2-OXO-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-ylpiperidines used as CGRP antagonists | |
IL184677A0 (en) | Substituted 1,1,1-trifluoro-3-[(benzyl)- | |
PL1693133T3 (pl) | Uchwyt narzędziowy | |
EP1736474A4 (en) | piperidine | |
ZA200710564B (en) | Thrombin inhibiting 2-oxo- 1,2,5,6-tetrahydropyridine derivatives | |
ZA200804956B (en) | 3,5-substituted piperidine compounds as renin inhibitors | |
IL187533A0 (en) | Novel piperidine derivative | |
IL188111A0 (en) | 2,5-bis-diamimne [1,4] benzoquinone-derivatives | |
ZA200709230B (en) | Novel piperidine derivatives | |
IL194972A0 (en) | 2-alkoxy-3,4,5-trihydroxy-alkylamide- | |
EP1711189A4 (en) | AZALIDE DERIVATIVES 8A 6,11-3C-BICYCLIC | |
ZA200702193B (en) | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds | |
AU2004100103A4 (en) | Bar B See |